Guía de Práctica Clínica sobre Trastorno Bipolar - GuíaSalud

214. Vieta E, Ramey T, Keller D, English PA, Loebel AD y Miceli J. Ziprasidone in the
treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study. J
Psychopharmacol, 2010; 24 (4): 547-558.
215. Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP y Versavel M. Ziprasidone plus a
mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebocontrolled,
double-blind trial. J Clin Psychiatry, 2010; 71 (2): 130-137.
216. McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA y Panagides J. Asenapine for longterm
treatment of bipolar disorder: a double-blind 40-week extension study. J Affect
Disord, 2010; 126 (3): 358-365.
217. McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA y Panagides J. Asenapine in the
treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebocontrolled
trial. J Affect Disord, 2010; 122 (1-2): 27-38.
218. Calabrese J, Stet L, Kotari H, Zhao J, Kouassi A, Szegedi A y Panagides J. Asenapine as
adjunctive treatment for bipolar mania: a placebo-controlled 12-week study and 40-week
extension. European psychiatry : the journal of the Association of European Psychiatrists,
2010; 25: 1447.
219. Calabrese J, Cohen M, Zhao J y Panagides J. Efficacy and safety of asenapine as
adjunctive treatment for acute mania associated with bipolar disorder. Annual Meeting of
the American Psychiatric Association; 2008; Whasington DC; 2008.
220. Berwaerts J, Lane R, Nuamah IF, Lim P, Remmerie B y Hough DW. Paliperidone
extended-release as adjunctive therapy to lithium or valproate in the treatment of acute
mania: a randomized, placebo-controlled study. J Affect Disord, 2011; 129 (1-3): 252-
260.
221. Vieta E, Nuamah IF, Lim P, Yuen EC, Palumbo JM, Hough DW y Berwaerts J. A
randomized, placebo- and active-controlled study of paliperidone extended release for the
treatment of acute manic and mixed episodes of bipolar I disorder. Bipolar Disord, 2010;
12 (3): 230-243.
222. Janicak PG, Sharma RP, Pandey G y Davis JM. Verapamil for the treatment of acute
mania: a double-blind, placebo-controlled trial. American Journal of Psychiatry, 1998;
155: 972-973.
223. Yildiz A, Guleryuz S, Ankerst DP, Ongur D y Renshaw PF. Protein kinase C inhibition in
the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Archives of
General Psychiatry, 2008; 65 (3): 255-263.
224. Machado-Vieira R, Soares JC, Lara DR, Luckenbaugh DA, Busnello JV, Marca G,
Cunha A, Souza DO, Zarate CA, Jr. y Kapczinski F. A double-blind, randomized,
placebo-controlled 4-week study on the efficacy and safety of the purinergic agents
allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin
Psychiatry, 2008; 69 (8): 1237-1245.
225. Zarate C, Singh J, Carlson P, Quiroz J, Jolkovsky L, Luckenbaugh D y HK M. Efficacy
of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.
Bipolar Disord 2007; 9: 561-570.
226. Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M,
Ghebleh F, Ahmadi-Abhari SA, Sadeghi M, Tabrizi M y Akhondzadeh S. Double-blind,
randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen
adjunctive to lithium in acute bipolar mania. J Affect Disord, 2011; 129 (1-3): 327-331.
227. Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R,
Dossenbach M, Kiesler G, Brook S y Wright P. A double-blind, placebo-controlled
doseresponse comparison of intramuscular olanzapine and haloperidol in the treatment of
acute agitation in schizophrenia. Arch Gen Psychiatry, 2002; 59 (5): 441-448.
228. Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud RA y Gharabawi G.
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with
risperidone and lorazepam versus intramuscular treatment with haloperidol and
lorazepam. Journal of Clinical Psychiatry, 2004; 65: 386-394.
412 SANIDAD